|
healthlaw reference
-Summer 2003 -
OIG Issues Pharmaceutical Compliance
Guidance
By Michael
A. Cassidy, Esq.
In April 2003, the
Office of Inspector General (OIG) of the U.S. Department of Health and
Human Services (HHS) issued "Compliance Program Guidance for
Pharmaceutical Manufacturers" (CPG). As usual, OIG described its
compliance pronouncements as "guidance" rather than a mandatory
compliance program, and acknowledged that the degree to which a
pharmaceutical business could adhere to or follow this guidance would
depend upon its resources. However, the CPG does identify the potential
benefits of a compliance program, the areas considered by the OIG to be
significant risk areas in the pharmaceutical industry, and the basic
elements of a compliance program.
Benefits of a Compliance Program
"The OIG believes a comprehensive
compliance program provides a mechanism that addresses the public and
private sectors’ mutual goals of reducing fraud and abuse; enhancing
health care provider operational functions; improving the quality of
health care services; and reducing the cost of health care." The OIG
also believes that pharmaceutical manufacturers can obtain the following
"important additional benefits" from establishing a voluntary compliance
program:
-
A concrete demonstration to employees and the community at large of the
company’s commitment to honest and responsible corporate conduct.
-
An increased likelihood of preventing, or at least identifying and
correcting, unlawful and unethical behavior at an early stage;
-
A mechanism to encourage employees to report potential problems and
allow for appropriate internal inquiry and corrective action; and
-
Through early detection and reporting, minimizing any financial loss to
the government and any corresponding financial loss to the company.
Industry Risk Areas
One purpose of the OIG’s various
compliance announcements is to alert various sections of the healthcare
industry to the specific risk areas within that industry. For the
pharmaceutical industry, the OIG has identified three significant risk
areas:
-
Integrity of Data Used to Establish or Determine Government
Reimbursement,
-
Kickbacks and Other Illegal Remuneration, and
-
Compliance With Laws Regulating Drug Samples.
The CPG then proceeds to identify
specific types of conduct within these various risk areas which should
be closely
examined in light of these basic
concerns.
Data Integrity and Reimbursement
Since the Medicare reimbursement
program is predicated upon a reimbursement formula, i.e. 95% of the
Average Wholesale Price, the integrity of the data submitted by the
manufacturers in order to establish the Average Wholesale Price is a
critical component.
In addition to determining the
appropriate reimbursement, there are a host of reimbursement - related
areas which the OIG identifies as risk areas, such as:
-
Product support services like billing assistance and reimbursement
consultation,
-
Reimbursement guarantees linked to federal reimbursement,
-
3. Product switching fees paid when customers or physicians switch drug
brands, and
-
Detailing payments, ie. payments to
compensate physicians for the time spent listening to the pharmaceutical
manufacturers product presentations.
Kickbacks and Illegal Remuneration
Because kickbacks, i.e. remuneration in
exchange for prescribing certain drugs, is one of the major risk areas
the OIG reviewed a number of traditionally accepted practices. While
acknowledging that the practices were not illegal per se, the OIG
cautioned the industry that safeguards must be present, such as FMV,
independent conduct, etc., in the following areas:
-
Educational grants,
-
Research sponsorship,
-
Formulary relationship, and
-
Consulting/medical director’s positions.
The OIG also devoted a sub-section of
the kickback analysis to gifts and business courtesies, making specific
reference to the PhRMA Code. The PhRMA Code is a set of voluntary
marketing guidelines adopted by the Pharmaceutical Research and
Manufacturers of America, a major industry association, effective July
1, 2002. It concentrates primarily upon the ethical and effective
marketing of pharmaceuticals. The focus of the PhRMA Code is upon the
interactions of pharmaceutical representatives and healthcare
professionals, and the thesis is that all interactions should be
intended to benefit patients, related to healthcare educational
activities, and should not provide incidental benefits with the
exception of occasional and modest meals.
The PhRMA code provides specific advice
regarding:
-
Informational presentations;
-
Third party educational meetings;
-
Use of consultants;
-
Speaker training meetings;
-
Scholarship and educational funds; and
-
Educational or practice related items.
Drug Samples
The final significant risk area is the
provision of the free drug samples. Providing free samples for the
benefit of patients is a well-accepted practice in the industry, and one
that is encouraged by the OIG. However, the Prescription Drug Marketing
Act of 1987 (PDMA), 21 U.S.C. §353(c)(1), governs the distribution of
drug samples and prohibits the sale of samples. There have been several
recent high profile government actions against healthcare practitioners
and pharmaceutical companies in this area.
Michael A. Cassidy is the Chair of the
firm’s Health Care Practice Group. For more information on these issues,
please contact Mike Cassidy at 412.594.5515 or via e-mail at
mcassidy@tuckerlaw.com.
A copy of the CPG is available on the
OIG website at
http://oig.hhs.gov/fraud/complianceguidance.html #1. The PhRMA Code
can be accessed at that organizations website, i.e.
www.phrma.org.
^ Back to top
HIPAA’s Final Security Rule: Better
Than Expected
Just as providers are beginning to feel
comfortable with HIPAA’s privacy rule, the Department of Health and
Human Services ("HHS") released the final rule defining the electronic
security standards. The proposed rule, released August 12, 1998,
contained over 60 required implementation features, and made no
allowance for small providers. As a result, HHS received approximately
2,350 comments to the proposed rule. In the final rule published
February 20, 2003 HHS addressed those concerns and created a
comprehensive rule that provides flexibility for small entities. Most
covered entities will have until April 21, 2005 to comply with the new
standards; however, small health plans will have an extra year to become
compliant.
Who and What Is Covered By The Rule
The final rule makes the security
standard applicable to all covered entities. This is the same group
covered by the privacy rule and includes: (1) health plans, (2) health
care clearinghouses, and (3) health care providers who transmit health
information in electronic form. Covered entities must also implement
standards to cover any member of their work force who works from home,
or at an off site location.
The standards will apply to all
electronic protected health information an entity creates, receives,
maintains or transmits. Unlike the privacy rule, the security rule only
applies to information in electronic form. In response to numerous
comments, the final rule only applies to information in electronic form
prior to transmission. Thus paper to paper faxes, person to person
telephone calls and voice mail are not covered. The rule does apply to
telephone voice response and faxback programs because these operations
utilize pre-transmission electronic information. Note this guidance is
different from that given in the transaction standard and only applies
to the security rule.
Flexibility
In response to comments urging the HHS
to make the rule scalable to allow implementation by all entities, the
new rule vastly altered the standards and implementation specifications.
The standards are written very generally to allow compliance by all
sizes and types of entities. Some standards also contain implementation
specifications, which provide guidance on how the standards should be
implemented. These specifications are designated either as required or
addressable to allow for even more flexibility. Required specifications
must be implemented to comply with the rule; however, entities will have
discretion regarding the addressable specifications.
When a standard contains one or more
addressable specifications, the provider must choose whether to: (1)
implement the specification, (2) implement an alternative security
measure, or (3) not implement the specification or the alternative. When
making this choice entities must determine whether the specification is
reasonable or appropriate by looking at factors such as a risk analysis,
risk mitigation strategy, cost, measures currently in place, etc. If the
entity determines that the measure is appropriate and reasonable it must
implement it. If a company decides to implement an alternative, or not
implement the specification or an alternative, it must document its
decision and rationale, and explain how the standard is being met in
light of its choice. The generality of the standards and the flexibility
of the specifications allow companies, regardless of type and size, to
tailor a plan to fit their organization and comply with the rule.
The Standards
The rule breaks the standards into
three categories: (1) administrative safeguards, (2) physical
safeguards, and (3) technical safeguards. The administrative safeguard
category contains standards requiring the development of policies and
procedures that will allow an entity to secure its data and ensure its
availability. These standards address office procedure, management,
workforce protocols, etc. The physical safeguard category addresses the
security of the system itself, including the workstations and the
facilities where they are contained. The last category contains
standards relating to access controls, and dictates what procedures
users must utilize to access the electronic material. These standards
govern issues such as passwords, automatic logoff, etc.
Documentation
The rule requires that companies
develop and maintain documentation of all company policies and
procedures required under this rule. The documentation must be kept in
written or electronic form and updated as policies and procedures are
altered. This documentation must be maintained for six years. This
documentation should be available to any person who would need such
information. For the average provider this rule will require more
documentation than change. Most entities currently have password
protected computers and databases. Most entities currently back up their
files on a regular basis. Most entities do most of what is required by
this rule already. To become compliant with this rule, entities will
need to develop and maintain written documentation of what they already
do and fill in policies and procedures as necessary.
The attorneys at Tucker Arensberg are
working to develop compliance plans to meet the needs of our health care
clients. If you have any questions regarding the new security standards,
or what you need to do to prepare your office, please contact Mike
Cassidy in our health care group.
^ Back to top
Highlights of the New Tax Act
By
Michelle L. Kopnski,
Esq.
On May 28, 2003, President Bush signed
into law the Jobs and
Growth Tax Relief Reconciliation Act of 2003. The goal of this Act is to
stimulate the economy by lowering the maximum rate on capital gains and
most dividends, accelerating the income tax rate reductions that were
previously enacted, and increasing depreciation benefits for small
business owners who purchase property and equipment. The following is a
summary of the provisions of the Act.
Lowering of Maximum Rate on Capital
Gains
For all sales and exchanges which occur
on or after May 6, 2003, the Act lowers the tax rate on long-term
capital gains. For those taxpayers who are in a tax bracket higher than
15%, the tax rate on long-term capital gains is now 15% for the years
2003 through 2008. For those taxpayers who are in the 10% or 15%
bracket, the long-term capital gains rate is reduced to 5% for the years
2003 through 2007 with no taxes on long term capital gains in 2008.
There is no lowering of the maximum rate for short term capital gains.
Short-term capital gains remain subject to tax at ordinary income tax
rates.
For taxpayers who own mutual funds, the
lower tax rate on capital gains will apply generally to redemptions as
well as capital gains distributions from those funds. In the case of
capital gains distributions, the date on which the gains are realized by
the mutual fund is the date for determining whether the new lower
capital gains rate will apply. Thus, any capital gain which is realized
by a mutual fund on or after May 6, 2003 will be taxed at the new lower
rates, and any capital gain which is realized by the mutual fund before May 6, 2003 will be taxed
at the old law’s rates of 20% (or 10% depending upon a person’s tax
bracket.) With respect to installment sales, any capital gains that are
received on or after May 6, 2003 will be taxed at the new lower rates
even if the sale itself was entered into before May 6, 2003.
Lowering of Maximum Rate on
Dividends
Any "qualified dividend income" that is
received by a shareholder from either a domestic or qualified foreign
corporation will be generally taxed at the same rate as the rates that
apply to capital gains.
Therefore, for tax payers who are in a
tax bracket higher than 15%, dividends will be taxed at the 15% rate for
the years 2003 through 2008. Those taxpayers who are in the 10% or 15%
bracket will pay tax at the rate of 5% on their "qualified dividend
income" in 2003 through 2007, and will pay no tax on such dividends in
2008. A dividend will be considered "qualified dividend income" if the
taxpayer meets certain holding periods. For dividends from common stock,
the holding period is generally at least 60 days during the 120 day
period beginning 60 days before the stock becomes ex-dividend. For
dividends from preferred stock, the holding period is 90 days during the
180 day period beginning 90 days before the stock becomes ex-dividend.
There are a number of other exceptions
with respect to whether a dividend is to be treated as "qualified
dividend income." You should consult with your tax advisor prior to any
dividend trans-action which might cause you to lose the favorable tax treatment for such transaction. With
respect to distributions from mutual funds, that portion of any
distribution that is a dividend will be treated as "qualified dividend
income" on the taxpayer’s income tax return. However, distributions that
are short term capital gains will continue to be taxed at ordinary
income tax rates.
Acceleration of Child Credit and Tax
Rates
Effective for tax years 2003 and 2004,
the Act increases the amount of the child credit to $1,000. The credit
under the old law was $600 for 2003 and 2004. According to the terms of
the Act, the child credit is reduced to $700 after 2004, but increases
back to $1,000 in 2010. The amount of the credit will be reduced for
taxpayers whose "modified adjusted gross income" is over $110,000 for
married couples filing jointly.
For tax years 2003 and 2004, the
standard deduction for married taxpayers filing jointly will be twice
the amount of the standard deduction for single taxpayers. Under
"current" law, the standard deduction for couples filing jointly was
167% of the standard deduction for single taxpayers. For taxable years
after 2004, the standard deduction for married couples filing jointly
will return to 167% of the standard deduction for single taxpayers.
Similarly, the Act expands the 15% income tax bracket for married
taxpayers filing joint returns so that it is now double the 15% income
tax bracket for single taxpayers. This expansion of the 15% rate bracket
applies for tax years 2003 and 2004. For tax years after 2004, the rate
bracket reverts to "current" law. Under "current" law, a reduction in
the regular tax rates was scheduled to occur in 2004 and 2006. Under the
new Act, for tax years 2003 and thereafter, the new tax rates will be
15%, 25%, 28%, 33%, and 35%. Under current law, the rates were 15%, 27%,
30%, 35%, and 38.8%.
Increases in Depreciation Allowances
For all tax years ending after May 5,
2003, the Act provides an additional first year depreciation deduction
which is equal to 50% of the adjusted basis of "qualified property"
purchased. Generally speaking, "qualified property" is property to which
the Modified Accelerated Cost Recover System applies with a recovery
period of 20 years or less. In order for property to be considered
"qualified property", the property must be acquired after May 5, 2003
and before January 1, 2005. Unfortunately, if property was subject to a
binding written contract prior to May 6, 2003, the property will not
qualify. In addition to the increase in the depreciation allowance for
certain "qualified property", the Act also increases the maximum amount
that may be deducted under Section 179 of the Internal Revenue Code from
$25,000 to $100,000 with the phase-out threshold level raised from
$200,000 to $400,000 for property which is placed in service for tax
years beginning in 2003, 2004 and 2005.
Planning Opportunities
The Act creates a number of planning
opportunities for taxpayers who are able to take advantage of the lower
tax rates on long-term capital gains and dividend distributions. In
addition, the Act provides substantial tax savings for businesses that
purchase "qualified property" after May 6, 2003.
Michelle Kopnski is an attorney in the
firm’s Health Care Practice Group. For more information on this topic,
please contact Michelle at 412.594.5522 or via e-mail at
mkopnski@tuckerlaw.com.
^ Back to top
In each issue, we spotlight
a member
of the Health Care Practice
Group.
In this issue, we spotlight...
MICHELLE L. KOPNSKI
Michelle L. Kopnski, an attorney in the
firm’s Health Care Practice Group, concentrates her practice in the
areas of corporate transactions, federal, state and local taxation and
non-profit and tax-exempt entities. Michelle has her LL.M., an advanced
tax degree, from the prestigious masters program at the New York
University School of Law.
Michelle’s practice also includes a
concentration in complex corporate transactions including negotiation,
analysis, documentation and implementation of mergers, acquisitions and
divestitures involving public and privately held companies; creation and
implementation of start-up and business development strategies for
manufacturing and service organizations; design of partnership and
limited liability company transactions; additional practice
concentration in federal, state and local taxation; negotiation and
management of corporate tax positions with IRS appellate officers;
preparation and presentment of corporate tax petitions before
commonwealth revenue and appellate boards; and formation and
representation of non-profit and tax-exempt entities.
Michelle has experience handling
extensive design, structuring and management of employee benefit
programs including primary responsibility for coordination of benefit
programs for a 20,000+ employee public company and its subsidiaries,
which maintained nine separate employee benefit plans. She has also
dealt with issues of ERISA and DOL compliance in employee plan
administration.
Michelle received her undergraduate degree from West Virginia
University, her law degree from West Virginia University College of Law.
Michelle is licensed to practice in Pennsylvania and West Virginia.
^ Back to top
Proposed COBRA Regulations:
In an effort to ensure that individuals receive accurate and timely
information regarding their right to continuation of health care
coverage under the Consolidated Omnibus Budget Reconciliation Act
(COBRA), the Department of Labor released proposed regulations which
clarify both the timing and content of required notices. The proposed
regulations identify the information that must be included in the
notices given: (1) to individuals by employers when the individuals
first become covered by a group health plan; (2) to group health plans
by employers or employees after a qualifying event; and (3) to
individuals by plan administrators regarding the COBRA election. The
proposed regulations are scheduled to be effective on January 1, 2004
for most group health plans.
Flex Accounts: Debit & Credit
The IRS recently released guidance on
the use of debit and credit cards for the reimbursement of medical
expenses under a health flexible spending account or health
reimbursement account. The guidance, released as Revenue Ruling 2003-43,
provides guidelines on how to implement a debit and credit card
arrangement and illustrates the substantiation requirements that must be
met in order for the reimbursements to be excluded from an employee’s
federal taxable income. Employers contemplating such an arrangement
should consider this guidance carefully.
For a copy of the guidance, please
contact Rich Kennedy at 412.594.5507.
^ Back to top
< Back

|